Requiem for a Panic Attack: More Large Studies Vindicate Gadolinium Contrast

Five years after the first reports linking gadolinium-based MRI contrast agents to nephrogenic system fibrosis , separate presentations of post-marketing data from manufacturers and an independent prospective study supported by agencies in France have validated the low-risk status of the contrast agent Dotarem . (27 secs ago)

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google